About us

About us

MicroBioSensor is led by serial biotechnology entrepreneurs, Curtis Dobson and Gordon Baker, alongside a team of experienced executive and non-executive directors.


Our Team

Curtis Dobson BSc, PhD, FRSB

Executive Chairman and Co-Founder

  • 20 years’ experience of technology commercialisation.
  • Professor of Translational Biology, University of Manchester (2010-date). Research sponsored by US and EU medical device / consumer health companies. Multiple granted patent holder.
  • Deputy Associate Dean for Business Engagement, Faculty of Biology Medicine and Health, University of Manchester.
  • Member of BBSRC Bioscience for Industry Strategy Panel.
  • Founder / CEO of Ai2 Ltd. (2003-2010). Negotiated licensing deals with global medical device companies.
  • BBSRC Commercial Innovator of the Year 2014. Winner of four Bionow Awards.

Gordon Barker BSc, PhD, MBA

CEO and Co-founder

  • Leads commercial activity. Overall responsibility for investor relations and company operations.
  • Serial life sciences entrepreneur, having helped found 4 University spinouts (incl. C4X Discovery and Gentronix).
  • Successful track-record in growing early stage businesses, raising investment and securing key commercial partnerships with leading international firms.
  • Chairman of Keswick Mountain Rescue Team (2014 – to date).

Darren Kell BSc, PhD PMP

Product Development Manager

  • Leads product development activity in the company.
  • 20 years experience developing and commercialising new products.
  • Successful new product introductions across commercial/industrial equipment, pharmaceuticals, and medical devices.
  • Professional Member of the Project Management Institute (PMP)

Nishal Govindji-Bhatt BSc, PhD


  • 12 years’ experience as a medical microbiologist.
  • Lead scientist for all company research programmes.
  • Bionow Healthcare Project of the Year 2017 award winner (STAR technology for UTI diagnosis).
  • Research Associate (Manchester University). Developed core MicroBioSensor technology.
  • Research Scientist Neutec Pharma (Novartis, 2007-2009).

Peter Foster BSc, PhD

Non-Executive Director

  • 35 years’ experience in senior management / board roles in the medical / biotech sector, & experience of taking numerous IVDs to market.
  • Amersham (Medical diagnostics R&D project leader).
  • Serono Diagnostics (R&D manager).
  • Shield Diagnostics/Axis Shield (Technical Director and Board Director).
  • Euro-Diagnostica (CEO and Board Director).
  • Pacific Edge (Non-Executive Director).
  • Pictor Limited (Non-Executive Director).
  • Symansis (CEO and Board Director).
  • Epistem Limited (Technical Director).

Professor William Kilgallon BSc, PhD MBA, FICM

Non-Executive Director

  • 33 years’ experience in peritoneal dialysis business development.
  • Cybex Ventures, CEO (2010-date).
  • Baxter Healthcare (Chicago/London), Senior Vice President for Global Strategy (2007-2009).
  • Fresenius Healthcare (Frankfurt / London), Vice President (2000-2007).
  • Baxter Healthcare (Belgium), Global Marketing Director (1998-2000).
  • Baxter Healthcare (Belgium), European Marketing Director (1996-1998).
  • Sigma-Aldrich (UK) (Business Development Director) (1988-1993).